This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 23/2/289    most recent 01.ATV.0000051382.28752.FEv1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meirhaeghe, A. Articles by Amouyel, P. Search for Related Content PubMed PubMed Citation Articles by Meirhaeghe, A. Articles by Amouyel, P. Related Collections Transplantation CV surgery: coronary artery disease

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:289.)
© 2003 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

A Functional Polymorphism in a STAT5B Site of the Human PPAR3 Gene Promoter Affects Height and Lipid Metabolism in a French Population

Aline Meirhaeghe; Lluis Fajas; Fabrice Gouilleux; Dominique Cottel; Nicole Helbecque; Johan Auwerx; Philippe Amouyel

From the Service d’Epidémiologie et de Santé Publique, INSERM U.508 (A.M., D.C., N.H., P.A.), Institut Pasteur de Lille; IGBMC (L.F., J.A.), Illkirch; Faculté de Médecine (F.G.), CHU d’Amiens, Amiens Cedex; and Centre Hospitalier et Universitaire de Lille (P.A.), Lille, France.

Correspondence to Pr. Philippe Amouyel, Service d’Epidémiologie et de Santé Publique, INSERM U.508, Institut Pasteur de Lille, 1 rue Calmette, BP 245, 59019 Lille Cedex, France. E-mail Philippe.Amouyel{at}pasteur-lille.fr

Objective— The peroxisome proliferator-activated receptor- (PPAR) plays a role in adipocyte differentiation and insulin sensitization. It has been shown that genetic variation in the PPAR gene alters body weight control, lipid and insulin homeostasis, and the susceptibility to type 2 diabetes. Four PPAR isoforms are generated by alternative splicing and promoter usage. PPAR3 is only expressed in adipose tissue, colon, and macrophages and therefore seems to be a good candidate gene for metabolic and cardiovascular-associated diseases. In the present study, we looked for genetic variation in the PPAR3 promoter.

Methods and Results— The proximal PPAR3 promoter was sequenced in 20 individuals. We detected a C/G polymorphism at position -681 from exon A2. Interestingly, it was located in a signal transducer and activator of transcription 5B (STAT5B) binding consensus site. In a French population (n=836), the -681G allele was associated with increased height and plasma low-density lipoprotein cholesterol concentrations. In vitro, we showed that the -681G allele completely abolished the binding of STAT5B to the cognate promoter element as well as the transactivation of the PPAR3 promoter by the growth hormone/STAT5B pathway.

Conclusions— Our results suggest that PPAR3 may regulate the control of height and lipid homeostasis via the STAT5B pathway.

Key Words: obesity • cholesterol • PPAR • growth hormone • STAT

This article has been cited by other articles:

				P. Dentelli, A. Trombetta, G. Togliatto, A. Zeoli, A. Rosso, B. Uberti, F. Orso, D. Taverna, L. Pegoraro, and M. F. Brizzi Formation of STAT5/PPAR{gamma} Transcriptional Complex Modulates Angiogenic Cell Bioavailability in Diabetes Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 114 - 120. [Abstract] [Full Text] [PDF]

				D. Chen, G. Jin, Y. Wang, H. Wang, H. Liu, Y. Liu, W. Fan, H. Ma, R. Miao, Z. Hu, et al. Genetic variants in peroxisome proliferator-activated receptor-{gamma} gene are associated with risk of lung cancer in a Chinese population Carcinogenesis, February 1, 2008; 29(2): 342 - 350. [Abstract] [Full Text] [PDF]

				J. E Cecil, C. N. Palmer, B. Fischer, P. Watt, D. J Wallis, I. Murrie, and M. M Hetherington Variants of the peroxisome proliferator-activated receptor {gamma}- and {beta}-adrenergic receptor genes are associated with measures of compensatory eating behaviors in young children Am. J. Clinical Nutrition, July 1, 2007; 86(1): 167 - 173. [Abstract] [Full Text] [PDF]

				X Han, N Benight, B Osuntokun, K Loesch, S J Frank, and L A Denson Tumour necrosis factor {alpha} blockade induces an anti-inflammatory growth hormone signalling pathway in experimental colitis Gut, January 1, 2007; 56(1): 73 - 81. [Abstract] [Full Text] [PDF]

				X. Han, B. Osuntokun, N. Benight, K. Loesch, S. J. Frank, and L. A. Denson Signal Transducer and Activator of Transcription 5b Promotes Mucosal Tolerance in Pediatric Crohn's Disease and Murine Colitis Am. J. Pathol., December 1, 2006; 169(6): 1999 - 2013. [Abstract] [Full Text] [PDF]

				Y.-Z. Liu, Y.-F. Guo, P. Xiao, D.-H. Xiong, L.-J. Zhao, H. Shen, Y.-J. Liu, V. Dvornyk, J.-R. Long, H.-Y. Deng, et al. Epistasis between Loci on Chromosomes 2 and 6 Influences Human Height J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3821 - 3825. [Abstract] [Full Text] [PDF]

				L Dubuquoy, C Rousseaux, X Thuru, L Peyrin-Biroulet, O Romano, P Chavatte, M Chamaillard, and P Desreumaux PPAR{gamma} as a new therapeutic target in inflammatory bowel diseases. Gut, September 1, 2006; 55(9): 1341 - 1349. [Full Text] [PDF]

				W.-P. Koh, J.-M. Yuan, D. Van Den Berg, S. A. Ingles, and M. C. Yu Peroxisome proliferator-activated receptor (PPAR) {gamma} gene polymorphisms and colorectal cancer risk among Chinese in Singapore Carcinogenesis, September 1, 2006; 27(9): 1797 - 1802. [Abstract] [Full Text] [PDF]

				A. Meirhaeghe, D. Cottel, P. Amouyel, and J. Dallongeville Association Between Peroxisome Proliferator-Activated Receptor {gamma} Haplotypes and the Metabolic Syndrome in French Men and Women Diabetes, October 1, 2005; 54(10): 3043 - 3048. [Abstract] [Full Text] [PDF]

				C. Knouff and J. Auwerx Peroxisome Proliferator-Activated Receptor-{gamma} Calls for Activation in Moderation: Lessons from Genetics and Pharmacology Endocr. Rev., December 1, 2004; 25(6): 899 - 918. [Abstract] [Full Text] [PDF]